6 assets in Manic Bipolar Affective Disorder

Therapeutic assets addressing Manic Bipolar Affective Disorder, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Lumateperone Manic Bipolar Affective Disorder	Intra-Cellular Therapies, Inc.	P3	B (60)
Trospium Manic Bipolar Affective Disorder	Bristol-Myers Squibb	P3	B (60)
Xanomeline Manic Bipolar Affective Disorder	Bristol-Myers Squibb	P3	B (60)
Nbi-1117568 Manic Bipolar Affective Disorder	Neurocrine Biosciences	P2	CCC (53)
Maltodextrin Manic Bipolar Affective Disorder	Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)	N/A	D (30)
Sodium Alginate Manic Bipolar Affective Disorder	Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)	N/A	D (30)